Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Syros Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the Cantor Virtual Global Healthcare Conference. Details are as follows:

Cantor Virtual Global Healthcare Conference:
Date: Thursday, September 17
Time: 8:40 a.m. ET

A live webcast of the presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

About Syros Pharmaceuticals

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust pipeline, including SY-1425, a first-in-class oral selective RAR? agonist in a Phase 2 trial in a genomically defined subset of acute myeloid leukemia patients, and SY-5609, a highly selective and potent oral CDK7 inhibitor in a Phase 1 trial in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

These press releases may also interest you

at 14:30
The "Enteral Feeding Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The report reviews, analyzes and projects the global Enteral Feeding Devices market for the period 2017-2026 in terms of Units and...

at 14:06
Vida Health is launching a new partnership with Bettermeant Health to provide thousands of U.S. military personnel with Vida's best-in-class mental health solutions to address resilience as well as stress, sleep, depression, and anxiety. This...

at 14:05
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and...

at 14:05
MACRO Trials (MACRO) understands that clinical trials are designed to find therapeutics and treatments for the total population; however, marginalized communities are generally not recruited or selected to participate in research studies. Especially...

at 14:04
Workers at 11 Tenet Healthcare hospitals in California have voted overwhelmingly to go on strike to demand that the giant hospital chain bargain in good faith with employees over health, safety, and other working conditions in their facilities, as...

at 14:01
Today, the PMPRB, under the National Prescription Drug Utilization Information System (NPDUIS) initiative, released a chartbook on the market for oncology medicines in Canada. The Oncology Medicines in Canada chartbook examines Canadian and...

News published on 10 september 2020 at 08:35 and distributed by: